Shitara et al., 2017
15 IL-17 promotes airway remodeling through goblet cell hyperplasia and smooth muscle proliferation, while stimulating structural cells to release neutrophil-activating factors like CXCL8/IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF), and TNF-
Conditions Addressed by NAD+ IV Therapy: Energy & Performance Issues: Chronic fatigue and low energy Reduced athletic performance and recovery Metabolic inefficiency Age-related decline in stamina Cognitive Concerns: Brain fog and poor concentration Memory difficulties Mood fluctuations Age-related cognitive changes Recovery & Restoration Needs: Addiction recovery support Cellular damage from toxin exposure Mitochondrial dysfunction Support during detoxification protocols Youre An Ideal Candidate If: Youre experiencing symptoms of reduced NAD+ levels such as fatigue, brain fog, or decreased physical performance, or if youre proactively seeking to optimize your cellular health and longevity pathways
Moreover, careful longitudinal studies will be needed to ascertain the duration of any protective immunity and potential disease enhancement for each vaccine candidate 148
Ma Y, Yang X, Pan P, Yang J, Wu X, Wang D, et al